IL6 and breast carcinoma: In breast cancer patients with advanced disease, treatment with taxanes systematically increased serum levels of various cytokines (eg. IFN-ɣ, IL-6 and GM-CSF) as well as the cytotoxic function of natural killer (NK) cells [86].